Bamco Inc Legend Biotech Corp Transaction History

Bamco Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$43.55 - $59.88 $6.15 Million - $8.45 Million	-141,106 Reduced 45.63%	168,158 $8.19 Million
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $1.28 Million - $1.86 Million	32,437 Added 11.72%	309,264 $13.7 Million
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $5.36 Million - $6.81 Million	97,259 Added 54.16%	276,827 $15.5 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $1.28 Million - $1.56 Million	22,368 Added 14.23%	179,568 $10.8 Million
Q3 2023 Nov 14, 2023	BUY	$63.16 - $76.5 $5.78 Million - $7 Million	91,500 Added 139.27%	157,200 $10.6 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $1.19 Million - $1.93 Million	25,700 Added 64.25%	65,700 $4.54 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $173,680 - $229,480	4,000 Added 11.11%	40,000 $1.93 Million
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $1.4 Million - $2 Million	36,000 New	36,000 $1.8 Million

230

86M

260K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.1B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.